Mrs Kitty St Pierre
Casual Academic
School of Pharmacy and Pharmaceutical Sciences
Book Chapter
St Pierre, Kitty I., Hill, Katherine and Staatz, Christine E. (2025). Considering kidney and liver function when prescribing and reviewing medicines in older people. Polypharmacy and geriatrics. (pp. 207-229) edited by Nagham J. Ailabouni. Cham, Switzerland: Springer Cham. doi: 10.1007/978-3-031-77314-3_8
Journal Articles
St Pierre, Kitty, El-Damanawi, Ragada, Jefferis, Julia, Johnson, David W., Hawley, Carmel M., Staatz, Christine E., Viecelli, Andrea K. and Mallett, Andrew J. (2025). Endpoint selection in autosomal dominant polycystic kidney disease clinical trials. Kidney International Reports. doi: 10.1016/j.ekir.2025.09.024
St Pierre, Kitty, El-Damanawi, Ragada, Johnson, David W., Hawley, Carmel M., Viecelli, Andrea K., Jha, Vivekanand, Green, Suetonia C., Gesualdo, Loreto, Kiriwandeniya, Charani, Velayudham, Pushparaj, Vergara, Liza A., Mihala, Gabor, Matsuyama, Misa, Brent, Peta-Ann Paul, Mallett, Andrew J. and IMPEDE-PKD Global Steering Committee (2025). Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease. Trials, 26 (1) 302. doi: 10.1186/s13063-025-09010-6
St Pierre, Kitty, Cashmore, Brydee, Cumpston, Miranda S., Hill, Kelvin, McDonald, Steve, Pattuwage, Loyal, White, Heath, Whittle, Samuel L., Turner, Tari and Tunnicliffe, David J. (2025). Methods for living guidelines: Paper 6: Insights from ALEC’s use of existing systematic reviews in living guideline development. Journal of Clinical Epidemiology 111812. doi: 10.1016/j.jclinepi.2025.111812
St Pierre, Kitty, Cashmore, Brydee A, Bolignano, Davide, Zoccali, Carmine, Ruospo, Marinella, Craig, Jonathan C, Strippoli, Giovanni FM, Mallett, Andrew J, Green, Suetonia C and Tunnicliffe, David J (2024). Interventions for preventing the progression of autosomal dominant polycystic kidney disease. Cochrane Database of Systematic Reviews, 2024 (10) CD010294, CD010294-10. doi: 10.1002/14651858.CD010294.pub3
El-Damanawi, Ragada, Stanley, Isabelle Kitty, Staatz, Christine, Pascoe, Elaine M., Craig, Jonathan C., Johnson, David W., Mallett, Andrew J., Hawley, Carmel M., Milanzi, Elasma, Hiemstra, Thomas F. and Viecelli, Andrea K. (2024). Metformin for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews, 2024 (6) CD013414, CD013414. doi: 10.1002/14651858.cd013414.pub2
Stanley, I. Kitty, Palma, Anton M., Viecelli, Andrea K., Johnson, David W., Hawley, Carmel M., Staatz, Christine E. and Mallett, Andrew J. (2024). A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials. Journal of Nephrology, 37 (5), 1417-1419. doi: 10.1007/s40620-024-01906-x
Stanley, Kitty, Mallett, Andrew J., Viecelli, Andrea K., Hawley, Carmel M., Staatz, Christine E., Johnson, David W. and Milanzi, Elasma (2024). A post hoc analysis of the CKD-FIX study analysing the association between metformin usage and eGFR decline. Kidney International Reports, 9 (5), 1525-1527. doi: 10.1016/j.ekir.2024.02.011
Stanley, Isabelle Kitty, Phoon, Richard K. S., Toussain, Nigel D., Cullen, Vanessa, Kearns, John, Dalbeth, Nicola, Johnson, David W., Krishnasamy, Rathika and Tunnicliffe, David J. (2022). Caring for Australians and New Zealanders With Kidney Impairment guidelines: rapid development of urate lowering therapy guidelines for people with CKD. Kidney International Reports, 7 (12), 2563-2574. doi: 10.1016/j.ekir.2022.09.024
Stanley, Isabelle Kitty, Schultz, Kadin L., Gardiner, Kyle M. and Staatz, Christine E. (2021). Evaluating the utilisation and expenditure patterns of erythropoietin stimulating agents and immunosuppressants in Australian chronic kidney disease patients. Journal of Pharmaceutical Health Services Research, 12 (3), 350-356. doi: 10.1093/jphsr/rmab027
Conference Papers
Stanley, I., Palma, A., Viecelli, A., Johnson. D., Hawley, C., Staatz, C. and Mallett, A. (2023). A Secondary Analysis of Concurrent use of Metformin and Tolvaptan in ADPKD Tolvaptan Trials. Asian Pacific Society of Dialysis Access (APSDA) Conference, Cairns, QLD Australia, 22-24th October 2023. HOBOKEN: WILEY.
Stanley, I., Viecelli, A., Johnson, D., Hawley, C., Mallett, A., Staatz, C. and Milanzi, E. (2023). A post-hoc analysis of the CKD-FIX study analysing the association between metformin use and eGFR decline. Australian and New Zealand Society of Nephrology Conference, Cairns, QLD, Australia, 22-24 October 2023. HOBOKEN: WILEY.
Thesis
St Pierre, Kitty (2025). Establishing the role of metformin for ADPKD through therapeutic investigation and guideline development. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/b82c120